We are live on ! Find out more

Small Cap Biotechnology
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
SPTX
51
Seaport Therapeutics
SPTX
$1.13B
$1.13B $21.10 3.83%
SVRA icon
52
Savara
SVRA
$1.13B
$1.13B $5.51 4.17%
DRTS icon
53
Alpha Tau Medical
DRTS
$1.13B
$1.13B $12.50 5.59%
FBRX icon
54
Forte Biosciences
FBRX
$1.12B
$1.12B $54.78 8.24%
WVE icon
55
Wave Life Sciences
WVE
$1.12B
$1.12B $5.81 0.52%
CRVS icon
56
Corvus Pharmaceuticals
CRVS
$1.1B
$1.1B $13.07 4.46%
MGTX icon
57
MeiraGTx Holdings
MGTX
$1.09B
$1.09B $11.77 2.73%
IVA
58
Inventiva
IVA
$1.05B
$1.05B $4.46 1.11%
CGEM icon
59
Cullinan Oncology
CGEM
$1.05B
$1.05B $17.10 1.04%
VOR icon
60
Vor Biopharma
VOR
$1.04B
$1.04B $19.26 1.48%
ANRO icon
61
Alto Neuroscience
ANRO
$1.04B
$1.04B $26.78 0.26%
EYPT icon
62
EyePoint Inc
EYPT
$1.02B
$1.02B $12.19 2.25%
OLMA icon
63
Olema Pharmaceuticals
OLMA
$1.02B
$1.02B $11.70 0.34%
LXRX icon
64
Lexicon Pharmaceuticals
LXRX
$1.02B
$1.02B $2.29 0.43%
LBRX
65
LB Pharmaceuticals
LBRX
$1B
$1B $35.01 1.13%
MRVI icon
66
Maravai LifeSciences
MRVI
$997M
$997M $6.76 4.11%
AVTX icon
67
Avalo Therapeutics
AVTX
$976M
$976M $18.44 3.83%
JANX icon
68
Janux Therapeutics
JANX
$935M
$935M $15.33 2.48%
KURA icon
69
Kura Oncology
KURA
$922M
$922M $10.39 0.57%
PHAT icon
70
Phathom Pharmaceuticals
PHAT
$912M
$912M $11.44 1.38%
GERN icon
71
Geron
GERN
$911M
$911M $1.42 2.07%
ODTX
72
Odyssey Therapeutics
ODTX
$896M
$896M $18.66 5.6%
PHAR
73
Pharming Group
PHAR
$891M
$891M $12.62 4.18%
SANA icon
74
Sana Biotechnology
SANA
$885M
$885M $3.18 0.93%
TBPH icon
75
Theravance Biopharma
TBPH
$874M
$874M $16.86 0%
1 2
3
4 5

Small Cap Biotechnology Stocks at a Glance

Biotechnology companies research and develop novel drugs and therapies, often with no products yet on the market. Clinical-trial readouts and regulatory decisions drive binary stock moves, making pipeline breadth, cash runway, and partnership deals the key variables.

There are 180 small cap Biotechnology stocks — companies in the Biotechnology industry with a market cap between $250M and $2B — worth a combined $157B.

The largest by market cap are UroGen Pharma (URGN) at $2B, Mesoblast (MESO) at $1.99B and Palvella Therapeutics (PVLA) at $1.98B.

Among institutional investors, Aktis Oncology (AKTS) drew the most net new fund positions in Q1 2026: 69 funds opened new positions.

  • Combined market cap: $157B across 180 stocks.
  • Small Cap: market cap between $250M and $2B.
  • Largest constituent: UroGen Pharma (URGN), $2B market cap.
  • Most net new fund positions in Q1 2026: Aktis Oncology (AKTS), +69 holders.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q1 2026.